Medexus Pharmaceuticals Inc. (TSX:MDP)

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Sales and Marketing Services in The Pharmaceutical Industry	99.33M	108.33M	113.05M	108.10M	76.70M
Sales and Marketing Services in The Pharmaceutical Industry Growth	-8.31%	-4.18%	4.59%	40.93%	-3.71%
Total	99.33M	108.33M	113.05M	108.10M	76.70M
Total Growth	-8.31%	-4.18%	4.59%	40.93%	-3.71%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
United States	74.74M	68.61M	77.18M	78.94M	52.01M
United States Growth	8.93%	-11.10%	-2.23%	51.79%	-13.85%
Canada	24.59M	39.72M	35.87M	29.16M	24.70M
Canada Growth	-38.09%	10.72%	23.03%	18.06%	28.00%
Total	99.33M	108.33M	113.05M	108.10M	76.70M
Total Growth	-8.31%	-4.18%	4.59%	40.93%	-3.71%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error